Accessibility Menu

Amgen(FRA) AMG

Market Cap€205.41BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+1,274%
5 Year+97%
1 Year+51%
1 Month+11%
€371.60
-2.20%
-8.35Today
Amgen last closing stock price
MetricPriceDate
Last closeEUR 370.752026-08-31
Amgen stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.94%EUR 378.102026-08-24
1 month+11.44%EUR 332.702026-07-31
3 month+32.22%EUR 280.402026-06-02
Year to date+32.27%EUR 280.302025-12-30
1 year+51.3%EUR 245.052025-08-29
3 year+55.78%EUR 238.002023-09-01
5 year+97.42%EUR 187.802021-09-01
Since inception+1,273.54%EUR 27.662010-07-22

Amgen Financials at a Glance

Market Cap

€205.41BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€32.76K

Net Income (TTM)

€7.49K

EPS (TTM)

€13.80

P/E Ratio

27.53

Dividend

€8.52

Beta (Volatility)

-0.05 (Low)

Price

€371.60

Volume

0

Open

€371.80

Previous Close

€371.60

Daily Range

€371.60 - €372.00

52-Week Range

€230.00 - €380.90

Estimated Earnings Date

N/A

AMG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amgen

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Industry

Biotechnology

Employees

31,500

CEO

Robert A. Bradway, MBA

AMG Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

90.56%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.63%

Dividend Yield

2.24%

Payout Ratio

N/A

Stock Overview

Market Cap

€205.41BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

540.63M

Volume

0

Avg. Volume

76.015

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Amgen Performance Analysis

Amgen annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 24,826,486,80112.9%
20232023-12-31EUR 25,908,422,6724.4%
20242024-12-31EUR 30,722,274,18618.6%
20252025-12-31EUR 32,555,128,3196.0%
Amgen annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 11.5232.4%
20232023-12-31EUR 11.550.2%
20242024-12-31EUR 6.99-39.5%
20252025-12-31EUR 12.6180.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€8.66K

+1.1%

Gross Profit

€6.24K

+1.1%

Gross Margin

72.08%

+1.1%

Market Cap

€205.41BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€5.37

N/A

Employees

31,500

N/A

Net Income

€2.04K

+1.6%

EBITDA

€3.99K

+1.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€62.36K

+14.0%

Total Debt

€50.12K

+1.0%

Accounts Receivable

€8.95K

+1.2%

Inventory

€5.44K

+1.0%

Long Term Debt

€45.36K

+1.0%

Short Term Debt

€4.76K

+2.3%

Return on Assets

9.46%

+1.2%

Return on Invested Capital

11.91%

+0.9%

Free Cash Flow

€3.01K

+1.9%

Operating Cash Flow

€3.45K

+1.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About AMG

What is the current price of Amgen?

Amgen is trading at €371.60 per share.

What is the 52-week range for Amgen?

Over the past 52 weeks, Amgen has traded between €230.00 and €380.90.

How much debt does Amgen have?

As of the most recent reporting period, Amgen reported total debt of €50.12B.

How much cash does Amgen have on hand?

Amgen reported €12.24B in cash and cash equivalents in its most recent financial results.

What is Amgen’s dividend yield?

Amgen currently has a dividend yield of 2.24%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.